Literature DB >> 33060779

Reducing discomfort of eye drops prior to retinal examination in the neonatal intensive care unit.

Dan Ni Wang1, Kyla Lavery2, Stacey Dalgleish3, Alexandra Howlett3, Vivian E Hill2, Stephanie A Dotchin2.   

Abstract

OBJECTIVE: To evaluate the effectiveness in reducing pain by giving oral sucrose and non-pharmacological comfort measures prior to topical administration of mydriatic eye drops on premature infants undergoing retinopathy of prematurity (ROP) screening eye exams in a neonatal intensive care unit (NICU). STUDY
DESIGN: A prospective quality improvement study was conducted in the NICU where infants were given oral sucrose prior to administration of mydriatic eye drops while a second person performed facilitated tucking and containment. Premature Infant Pain Profile (PIPP) scores were recorded during eye drop administration and compared to a group that did not receive any comfort measures. RESULT: Sixty-eight infants were enrolled. Mean PIPP scores increased an average of 1.5 (SD = 1.5) during administration of mydriatic drops without comfort measures compared to 0.6 (SD = 0.8) when comfort measures were used. This difference was statistically significant (p < 0.001).
CONCLUSIONS: Oral sucrose and simple comfort measures can be effective in reducing pain associated with mydriatic eye drops.

Entities:  

Year:  2020        PMID: 33060779     DOI: 10.1038/s41372-020-00852-3

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  25 in total

1.  Transient paralytic ileus following the use of cyclopentolate-phenylephrine eye drops during screening for retinopathy of prematurity.

Authors:  D L Lim; M Batilando; V S Rajadurai
Journal:  J Paediatr Child Health       Date:  2003 May-Jun       Impact factor: 1.954

2.  The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study.

Authors:  William V Good; Robert J Hardy; Velma Dobson; Earl A Palmer; Dale L Phelps; Michelle Quintos; Betty Tung
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

3.  Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.

Authors:  Anita Mitchell; Richard W Hall; Stephen W Erickson; Charlotte Yates; Scott Lowery; Howard Hendrickson
Journal:  Curr Eye Res       Date:  2016-05-09       Impact factor: 2.424

4.  Physiologic effects of retinopathy of prematurity screening examinations.

Authors:  Anita J Mitchell; Angela Green; Debra A Jeffs; Paula K Roberson
Journal:  Adv Neonatal Care       Date:  2011-08       Impact factor: 1.968

5.  The efficacy of developmentally sensitive interventions and sucrose for relieving procedural pain in very low birth weight neonates.

Authors:  B Stevens; C Johnston; L Franck; P Petryshen; A Jack; G Foster
Journal:  Nurs Res       Date:  1999 Jan-Feb       Impact factor: 2.381

6.  A double-blind study comparing 0.5% and 1% tropicamide for annual retinal screening in diabetic adolescents.

Authors:  J Hassler-Hurst; C Wadham; G Rayman
Journal:  Diabet Med       Date:  2004-05       Impact factor: 4.359

7.  Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants.

Authors:  B J Lees; L A Cabal
Journal:  Pediatrics       Date:  1981-08       Impact factor: 7.124

8.  Must screening examinations for retinopathy of prematurity necessarily be painful?

Authors:  Lieselotte Kirchner; Valerie Jeitler; Arnold Pollak; Andrea Müllner-Eidenböck; Robert Weinzettel; Raimund Kraschl; Thomas Waldhör; Martin Wald
Journal:  Retina       Date:  2009-05       Impact factor: 4.256

9.  Cardiopulmonary arrest following administration of Cyclomydril eyedrops for outpatient retinopathy of prematurity screening.

Authors:  Jung M Lee; Sylvia R Kodsi; Majida A Gaffar; Steven E Rubin
Journal:  J AAPOS       Date:  2014-04       Impact factor: 1.220

10.  The pain response to mydriatic eyedrops in preterm infants.

Authors:  A M Cohen; N Cook; M C Harris; G-S Ying; G Binenbaum
Journal:  J Perinatol       Date:  2012-12-13       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.